INMUNE BIO INC. - COMMON STOCK

INmune Bio, Inc. Announces Fourth Quarter and Full Year 2020 Results and Provides Business Update

04 3 2021 16:15:00 提供 Nasdaq GlobeNewswire

INmune Bio, Inc. to Report Fourth Quarter and Full Year 2020 Financial Results and Provide a Corporate Update on Thursday, March 4

25 2 2021 09:00:00 提供 Nasdaq GlobeNewswire

INmune Bio, Inc. Announces XPro1595 Found to Decrease Neuroinflammation and Neurodegeneration Biomarkers in Patients with Alzheimer’s Disease in Phase 1b Trial

21 1 2021 07:00:00 提供 Nasdaq GlobeNewswire

INmune Bio, Inc. to Host Key Opinion Leader Webinar on Thursday, January 21 at 8 AM ET

13 1 2021 08:00:00 提供 Nasdaq GlobeNewswire